Faes Farma (FRA:FFEA) Notes Receivable: €0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:FFEA Faes Farma SA FRA:FFEA
90 GF Score
Price €4.29
GF Value €5.05
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Faes Farma Notes Receivable?

Faes Farma FRA:FFEA 90 Notes Receivable is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:FFEA with a GF Score™ of 90/100 and a GF Value™ of €5.05 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Faes Farma's Notes Receivable for the quarter that ended in Dec. 2025 was €0.0 Mil.

Faes Farma Notes Receivable Historical Data

* Premium members only.

The historical data trend for Faes Farma's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Faes Farma Notes Receivable Chart

Faes Farma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Faes Farma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:FFEA
90GF Score
Faes Farma SA FRA:FFEA
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Faes Farma Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.0 Mil mean?
Faes Farma (FRA:FFEA) has a Notes Receivable of €0.0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Faes Farma and its competitors.
Is Faes Farma's Notes Receivable too high?
Faes Farma's current Notes Receivable is €0.0 Mil. Overall, Faes Farma has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Notes Receivable compare to ZTS and UTHR?
Faes Farma's Notes Receivable of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Faes Farma and its competitors. Faes Farma's current Notes Receivable is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Based on GuruFocus' analysis, Faes Farma (FRA:FFEA) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.05, compared to a current price of €4.29 — trading 15% below its estimated fair value. The current Notes Receivable is €0.0 Mil. Faes Farma's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Faes Farma (FRA:FFEA), the current Notes Receivable is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Faes Farma (FRA:FFEA) Overvalued in 2026?

Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued. The current stock price of €4.29 is trading 15% below its estimated GF Value™ of €5.05. GuruFocus considers Faes Farma to be Modestly Undervalued.

Key valuation signals for FRA:FFEA:

  • Notes Receivable: €0.0 Mil
  • GF Value™: €5.05 vs. price of €4.29 (15% below fair value)
  • GF Score™: 90/100 with 7 warning signs

No single metric tells the full story. See the FRA:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Faes Farma Business Description

Other Exchanges 0K9H:UKFAE:Spain
Address Avenida Autonomia, 10, Leioa, Vizcaya, ESP, 48940
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
90GF Score

Get the complete analysis for FRA:FFEA

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.29
Price
€5.05
GF Value